Å·ÃÀAV

Phishing warning 01-May-2024
We are aware of phishing emails targeting speakers of events whose names appear on our events pages. If you are unsure if an email regarding event registration or accommodation has come from us please contact us and do not provide any credit card details or personal information.

What's new in immunotherapies 2022

7 June 2022, London, United Kingdom


Introduction
Immunotherapy is a hot-topic field of research that has generated significant scientific interest and fuelled industrial innovation.

It has been demonstrated that small, drug-like molecules can be highly effective modulators of immune response pathways and that their molecular properties can be fine-tuned to enable excellent cell permeability and bioavailability. This makes them ideal for use in the treatment of chronic conditions such as autoimmune and inflammation-related diseases. Excitingly, this approach also offers the possibility to treat cancer by harnessing the body’s own immune system to fight tumours.

This meeting will offer a broad introduction to those new to the topic and showcase recent innovations by academic and industrial scientists in this exciting and rapidly expanding field.

The event is targeted at research students, researchers, academic and industrial scientists engaged in all aspects of research into small molecule immunotherapy, and those interested in broadening their knowledge in this growing field.

Useful links

Speakers
  • Dr Rhoanne McPherson Concept Life Sciences, United Kingdom
  • Dr William McCoull Associate Director AstraZeneca, United Kingdom
  • Emmanuel Demont GSK, United Kingdom
  • Andrew Leishman Grey Wolf therapeutics, United Kingdom
  • Professor Edward Tate Imperial College, United Kingdom

Venue
SCI

SCI , 14-15 Belgrave Square, London, SW1X 8PS, United Kingdom

Contact information
Search
 
 
Showing all upcoming events
Start Date
End Date
Location
Subject area
Event type

Advertisement
Spotlight


E-mail Enquiry
*
*
*
*